Click for best price
Human Coagulation Factor IX Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor IX. This report contains market size and forecasts of Human Coagulation Factor IX in global, including the following market information:
Global Human Coagulation Factor IX Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Human Coagulation Factor IX Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Human Coagulation Factor IX companies in 2022 (%)
The global Human Coagulation Factor IX market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
AHGB Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Coagulation Factor IX include Grifols, Biogen, Octapharma, Baxter, Bayer, CSL, Novo Nordisk, Greencross and Kedrion, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Coagulation Factor IX manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Coagulation Factor IX Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IX Market Segment Percentages, by Type, 2022 (%)
AHGB
AHFB
Others
Global Human Coagulation Factor IX Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IX Market Segment Percentages, by Application, 2022 (%)
Hospital
Personal Clinic
Others
Global Human Coagulation Factor IX Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Coagulation Factor IX Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Coagulation Factor IX revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Coagulation Factor IX revenues share in global market, 2022 (%)
Key companies Human Coagulation Factor IX sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Human Coagulation Factor IX sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols
Biogen
Octapharma
Baxter
Bayer
CSL
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Coagulation Factor IX, market overview.
Chapter 2: Global Human Coagulation Factor IX market size in revenue and volume.
Chapter 3: Detailed analysis of Human Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Coagulation Factor IX capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Coagulation Factor IX Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Coagulation Factor IX Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Coagulation Factor IX Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Coagulation Factor IX Overall Market Size
2.1 Global Human Coagulation Factor IX Market Size: 2022 VS 2030
2.2 Global Human Coagulation Factor IX Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Human Coagulation Factor IX Sales: 2018-2030
3 Company Landscape
3.1 Top Human Coagulation Factor IX Players in Global Market
3.2 Top Global Human Coagulation Factor IX Companies Ranked by Revenue
3.3 Global Human Coagulation Factor IX Revenue by Companies
3.4 Global Human Coagulation Factor IX Sales by Companies
3.5 Global Human Coagulation Factor IX Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Coagulation Factor IX Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Coagulation Factor IX Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Coagulation Factor IX Players in Global Market
3.8.1 List of Global Tier 1 Human Coagulation Factor IX Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Coagulation Factor IX Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Coagulation Factor IX Market Size Markets, 2022 & 2030
4.1.2 AHGB
4.1.3 AHFB
4.1.4 Others
4.2 By Type - Global Human Coagulation Factor IX Revenue & Forecasts
4.2.1 By Type - Global Human Coagulation Factor IX Revenue, 2018-2023
4.2.2 By Type - Global Human Coagulation Factor IX Revenue, 2024-2030
4.2.3 By Type - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
4.3 By Type - Global Human Coagulation Factor IX Sales & Forecasts
4.3.1 By Type - Global Human Coagulation Factor IX Sales, 2018-2023
4.3.2 By Type - Global Human Coagulation Factor IX Sales, 2024-2030
4.3.3 By Type - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
4.4 By Type - Global Human Coagulation Factor IX Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Coagulation Factor IX Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Personal Clinic
5.1.4 Others
5.2 By Application - Global Human Coagulation Factor IX Revenue & Forecasts
5.2.1 By Application - Global Human Coagulation Factor IX Revenue, 2018-2023
5.2.2 By Application - Global Human Coagulation Factor IX Revenue, 2024-2030
5.2.3 By Application - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
5.3 By Application - Global Human Coagulation Factor IX Sales & Forecasts
5.3.1 By Application - Global Human Coagulation Factor IX Sales, 2018-2023
5.3.2 By Application - Global Human Coagulation Factor IX Sales, 2024-2030
5.3.3 By Application - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
5.4 By Application - Global Human Coagulation Factor IX Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Human Coagulation Factor IX Market Size, 2022 & 2030
6.2 By Region - Global Human Coagulation Factor IX Revenue & Forecasts
6.2.1 By Region - Global Human Coagulation Factor IX Revenue, 2018-2023
6.2.2 By Region - Global Human Coagulation Factor IX Revenue, 2024-2030
6.2.3 By Region - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
6.3 By Region - Global Human Coagulation Factor IX Sales & Forecasts
6.3.1 By Region - Global Human Coagulation Factor IX Sales, 2018-2023
6.3.2 By Region - Global Human Coagulation Factor IX Sales, 2024-2030
6.3.3 By Region - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Human Coagulation Factor IX Revenue, 2018-2030
6.4.2 By Country - North America Human Coagulation Factor IX Sales, 2018-2030
6.4.3 US Human Coagulation Factor IX Market Size, 2018-2030
6.4.4 Canada Human Coagulation Factor IX Market Size, 2018-2030
6.4.5 Mexico Human Coagulation Factor IX Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Human Coagulation Factor IX Revenue, 2018-2030
6.5.2 By Country - Europe Human Coagulation Factor IX Sales, 2018-2030
6.5.3 Germany Human Coagulation Factor IX Market Size, 2018-2030
6.5.4 France Human Coagulation Factor IX Market Size, 2018-2030
6.5.5 U.K. Human Coagulation Factor IX Market Size, 2018-2030
6.5.6 Italy Human Coagulation Factor IX Market Size, 2018-2030
6.5.7 Russia Human Coagulation Factor IX Market Size, 2018-2030
6.5.8 Nordic Countries Human Coagulation Factor IX Market Size, 2018-2030
6.5.9 Benelux Human Coagulation Factor IX Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Human Coagulation Factor IX Revenue, 2018-2030
6.6.2 By Region - Asia Human Coagulation Factor IX Sales, 2018-2030
6.6.3 China Human Coagulation Factor IX Market Size, 2018-2030
6.6.4 Japan Human Coagulation Factor IX Market Size, 2018-2030
6.6.5 South Korea Human Coagulation Factor IX Market Size, 2018-2030
6.6.6 Southeast Asia Human Coagulation Factor IX Market Size, 2018-2030
6.6.7 India Human Coagulation Factor IX Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Human Coagulation Factor IX Revenue, 2018-2030
6.7.2 By Country - South America Human Coagulation Factor IX Sales, 2018-2030
6.7.3 Brazil Human Coagulation Factor IX Market Size, 2018-2030
6.7.4 Argentina Human Coagulation Factor IX Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Coagulation Factor IX Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Human Coagulation Factor IX Sales, 2018-2030
6.8.3 Turkey Human Coagulation Factor IX Market Size, 2018-2030
6.8.4 Israel Human Coagulation Factor IX Market Size, 2018-2030
6.8.5 Saudi Arabia Human Coagulation Factor IX Market Size, 2018-2030
6.8.6 UAE Human Coagulation Factor IX Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Grifols
7.1.1 Grifols Company Summary
7.1.2 Grifols Business Overview
7.1.3 Grifols Human Coagulation Factor IX Major Product Offerings
7.1.4 Grifols Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.1.5 Grifols Key News & Latest Developments
7.2 Biogen
7.2.1 Biogen Company Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Human Coagulation Factor IX Major Product Offerings
7.2.4 Biogen Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.2.5 Biogen Key News & Latest Developments
7.3 Octapharma
7.3.1 Octapharma Company Summary
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Human Coagulation Factor IX Major Product Offerings
7.3.4 Octapharma Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.3.5 Octapharma Key News & Latest Developments
7.4 Baxter
7.4.1 Baxter Company Summary
7.4.2 Baxter Business Overview
7.4.3 Baxter Human Coagulation Factor IX Major Product Offerings
7.4.4 Baxter Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.4.5 Baxter Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Human Coagulation Factor IX Major Product Offerings
7.5.4 Bayer Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 CSL
7.6.1 CSL Company Summary
7.6.2 CSL Business Overview
7.6.3 CSL Human Coagulation Factor IX Major Product Offerings
7.6.4 CSL Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.6.5 CSL Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Human Coagulation Factor IX Major Product Offerings
7.7.4 Novo Nordisk Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Greencross
7.8.1 Greencross Company Summary
7.8.2 Greencross Business Overview
7.8.3 Greencross Human Coagulation Factor IX Major Product Offerings
7.8.4 Greencross Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.8.5 Greencross Key News & Latest Developments
7.9 Kedrion
7.9.1 Kedrion Company Summary
7.9.2 Kedrion Business Overview
7.9.3 Kedrion Human Coagulation Factor IX Major Product Offerings
7.9.4 Kedrion Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.9.5 Kedrion Key News & Latest Developments
7.10 BPL
7.10.1 BPL Company Summary
7.10.2 BPL Business Overview
7.10.3 BPL Human Coagulation Factor IX Major Product Offerings
7.10.4 BPL Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.10.5 BPL Key News & Latest Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Company Summary
7.11.2 Hualan Bio Human Coagulation Factor IX Business Overview
7.11.3 Hualan Bio Human Coagulation Factor IX Major Product Offerings
7.11.4 Hualan Bio Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.11.5 Hualan Bio Key News & Latest Developments
7.12 RAAS
7.12.1 RAAS Company Summary
7.12.2 RAAS Human Coagulation Factor IX Business Overview
7.12.3 RAAS Human Coagulation Factor IX Major Product Offerings
7.12.4 RAAS Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.12.5 RAAS Key News & Latest Developments
7.13 Pfizer
7.13.1 Pfizer Company Summary
7.13.2 Pfizer Human Coagulation Factor IX Business Overview
7.13.3 Pfizer Human Coagulation Factor IX Major Product Offerings
7.13.4 Pfizer Human Coagulation Factor IX Sales and Revenue in Global (2018-2023)
7.13.5 Pfizer Key News & Latest Developments
8 Global Human Coagulation Factor IX Production Capacity, Analysis
8.1 Global Human Coagulation Factor IX Production Capacity, 2018-2030
8.2 Human Coagulation Factor IX Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Coagulation Factor IX Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Coagulation Factor IX Supply Chain Analysis
10.1 Human Coagulation Factor IX Industry Value Chain
10.2 Human Coagulation Factor IX Upstream Market
10.3 Human Coagulation Factor IX Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Coagulation Factor IX Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Coagulation Factor IX in Global Market
Table 2. Top Human Coagulation Factor IX Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Coagulation Factor IX Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Coagulation Factor IX Revenue Share by Companies, 2018-2023
Table 5. Global Human Coagulation Factor IX Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Human Coagulation Factor IX Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Coagulation Factor IX Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Human Coagulation Factor IX Product Type
Table 9. List of Global Tier 1 Human Coagulation Factor IX Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Coagulation Factor IX Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Human Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Coagulation Factor IX Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Human Coagulation Factor IX Sales (K Pcs), 2018-2023
Table 15. By Type - Global Human Coagulation Factor IX Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Human Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Coagulation Factor IX Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Human Coagulation Factor IX Sales (K Pcs), 2018-2023
Table 20. By Application - Global Human Coagulation Factor IX Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Human Coagulation Factor IX Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Coagulation Factor IX Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Human Coagulation Factor IX Sales (K Pcs), 2018-2023
Table 25. By Region - Global Human Coagulation Factor IX Sales (K Pcs), 2024-2030
Table 26. By Country - North America Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Coagulation Factor IX Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Human Coagulation Factor IX Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Human Coagulation Factor IX Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Coagulation Factor IX Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Human Coagulation Factor IX Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Human Coagulation Factor IX Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Coagulation Factor IX Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Human Coagulation Factor IX Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Human Coagulation Factor IX Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Coagulation Factor IX Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Human Coagulation Factor IX Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Human Coagulation Factor IX Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Coagulation Factor IX Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Human Coagulation Factor IX Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Human Coagulation Factor IX Sales, (K Pcs), 2024-2030
Table 46. Grifols Company Summary
Table 47. Grifols Human Coagulation Factor IX Product Offerings
Table 48. Grifols Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Grifols Key News & Latest Developments
Table 50. Biogen Company Summary
Table 51. Biogen Human Coagulation Factor IX Product Offerings
Table 52. Biogen Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Biogen Key News & Latest Developments
Table 54. Octapharma Company Summary
Table 55. Octapharma Human Coagulation Factor IX Product Offerings
Table 56. Octapharma Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Octapharma Key News & Latest Developments
Table 58. Baxter Company Summary
Table 59. Baxter Human Coagulation Factor IX Product Offerings
Table 60. Baxter Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Baxter Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Human Coagulation Factor IX Product Offerings
Table 64. Bayer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. CSL Company Summary
Table 67. CSL Human Coagulation Factor IX Product Offerings
Table 68. CSL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. CSL Key News & Latest Developments
Table 70. Novo Nordisk Company Summary
Table 71. Novo Nordisk Human Coagulation Factor IX Product Offerings
Table 72. Novo Nordisk Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Novo Nordisk Key News & Latest Developments
Table 74. Greencross Company Summary
Table 75. Greencross Human Coagulation Factor IX Product Offerings
Table 76. Greencross Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Greencross Key News & Latest Developments
Table 78. Kedrion Company Summary
Table 79. Kedrion Human Coagulation Factor IX Product Offerings
Table 80. Kedrion Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Kedrion Key News & Latest Developments
Table 82. BPL Company Summary
Table 83. BPL Human Coagulation Factor IX Product Offerings
Table 84. BPL Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. BPL Key News & Latest Developments
Table 86. Hualan Bio Company Summary
Table 87. Hualan Bio Human Coagulation Factor IX Product Offerings
Table 88. Hualan Bio Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Hualan Bio Key News & Latest Developments
Table 90. RAAS Company Summary
Table 91. RAAS Human Coagulation Factor IX Product Offerings
Table 92. RAAS Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. RAAS Key News & Latest Developments
Table 94. Pfizer Company Summary
Table 95. Pfizer Human Coagulation Factor IX Product Offerings
Table 96. Pfizer Human Coagulation Factor IX Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Pfizer Key News & Latest Developments
Table 98. Human Coagulation Factor IX Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 99. Global Human Coagulation Factor IX Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Human Coagulation Factor IX Production by Region, 2018-2023 (K Pcs)
Table 101. Global Human Coagulation Factor IX Production by Region, 2024-2030 (K Pcs)
Table 102. Human Coagulation Factor IX Market Opportunities & Trends in Global Market
Table 103. Human Coagulation Factor IX Market Drivers in Global Market
Table 104. Human Coagulation Factor IX Market Restraints in Global Market
Table 105. Human Coagulation Factor IX Raw Materials
Table 106. Human Coagulation Factor IX Raw Materials Suppliers in Global Market
Table 107. Typical Human Coagulation Factor IX Downstream
Table 108. Human Coagulation Factor IX Downstream Clients in Global Market
Table 109. Human Coagulation Factor IX Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Coagulation Factor IX Segment by Type in 2022
Figure 2. Human Coagulation Factor IX Segment by Application in 2022
Figure 3. Global Human Coagulation Factor IX Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Coagulation Factor IX Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Coagulation Factor IX Revenue, 2018-2030 (US$, Mn)
Figure 7. Human Coagulation Factor IX Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Human Coagulation Factor IX Revenue in 2022
Figure 9. By Type - Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 11. By Type - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 12. By Type - Global Human Coagulation Factor IX Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 15. By Application - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 16. By Application - Global Human Coagulation Factor IX Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Human Coagulation Factor IX Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Human Coagulation Factor IX Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 20. By Region - Global Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 21. By Country - North America Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 22. By Country - North America Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 23. US Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 28. Germany Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 29. France Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 37. China Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 41. India Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 43. By Country - South America Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 44. Brazil Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Human Coagulation Factor IX Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Human Coagulation Factor IX Sales Market Share, 2018-2030
Figure 48. Turkey Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Human Coagulation Factor IX Revenue, (US$, Mn), 2018-2030
Figure 52. Global Human Coagulation Factor IX Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Human Coagulation Factor IX by Region, 2022 VS 2030
Figure 54. Human Coagulation Factor IX Industry Value Chain
Figure 55. Marketing Channels
